Imetelstat Sodium in Treating Participants With Primary or Secondary Myelofibrosis

Clinical trial NCT01731951 · COMPLETED

Trial details

NCT number: NCT01731951
Sponsor: Geron Corporation
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Primary Myelofibrosis Secondary Myelofibrosis Myeloid Malignancies

Start date: 2012-10-29
Primary completion: 2018-05-24
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.